The present nosography of somatoform disorders: results of the Italian epidemiological study of somatoform disorders

By Tacchini G.   Musazzi A.   Recchia M.   Altamura A.C.   Carta M.G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Sulpiride in the Treatment of Somatoform Disorders: Results of a European Observational Study to Characterize the Responder Profile

By Rouillon F   Rahola G   Van Moffaert M   Lopes R Guimaraes   Dunia J    

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 304-313

Field House Publishing

Access to resources Recommend Favorite

Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial

By Volz H.-P.   Moller H.-J.   Reimann I.   Stoll K.-D.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

Psychopharmacological treatments of somatoform disorders

By Altamura A.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 176-177

Elsevier

Access to resources Recommend Favorite

Focus on biological basis of somatoform disorders

By Del Zompo M.   Ruiu S.   Severino G.   Cherchi A.   Bocchetta A.   Usaia P.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 177-177

Elsevier

Access to resources Recommend Favorite